This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovator Spotlight: Makato Kawai
Introduction
Makato Kawai is a distinguished inventor based in Aichi-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research that led to the development of novel compounds.
Latest Patents
Kawai holds a patent for "5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists." This groundbreaking invention highlights his role in addressing medical challenges and advancing therapeutic options in pharmacology.
Career Highlights
Kawai is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work there reflects a commitment to scientific excellence and innovation, contributing valuable insights into drug development and research.
Collaborations
Throughout his career, Makato Kawai has collaborated with esteemed colleagues, including Takafumi Ikeda and Mitsuhiro Kawamura. These partnerships enhance the innovative capacity of his projects, fostering a collaborative environment that drives success in research and development.
Conclusion
Makato Kawai’s contributions to the field of pharmaceuticals exemplify the impact of innovation on healthcare. His achievements, particularly his patent for bradykinin antagonists, underscore the vital role of inventors in creating solutions that improve patient outcomes. As he continues his work at Pfizer Corporation, Kawai remains a key figure to watch in the ever-evolving landscape of pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile